Topping tamoxifen as 1st-line Rx for postmenopausal breast Ca

Article

Aromatase inhibitors should replace tamoxifen as the first choice for preventing recurrence of breast cancer in postmenopausal women with localized hormone receptor-positive disease, according to this large-scale study.

Recent Videos
Worse menopause symptom burden reported in rural women | Image Credit: uwmedicine.org.
Kameelah Phillips, MD, FACOG, NCMP, is featured in this series.
Dr. Thomas outlines the future of the Safe Baby Safe Moms program | Image Credit: medstarhealth.org.
How the Safe Baby Safe Moms program transforms maternal and child health | Image Credit: medstarhealth.org.
ASCCP guidelines highlight critical information for extended HPV genotyping | Image Credit: linkedin.com.
Self-collection and extended genotyping advance cervical cancer screening | Image Credit: linkedin.com.
New trends in cervical cancer screening: Self-collection and barriers to adherence | Image Credit: linkedin.com.
Kameelah Phillips, MD, FACOG, NCMP, is featured in this series.
Kameelah Phillips, MD, FACOG, NCMP, is featured in this series.
Related Content
© 2025 MJH Life Sciences

All rights reserved.